AXQ Capital
CGEM icon

AXQ Capital’s Cullinan Oncology CGEM Stock Holding History

AXQ Capital’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-14,935
Closed -$272K – 1095
2026
Q2 		$272K Buy
+14,935
New +$222K 0.03% 636
2025
Q4 		– Sell
-32,669
Closed -$194K – 750
2025
Q3 		$194K Buy
+32,669
New +$239K 0.07% 458
2025
Q2 		– Sell
-14,255
Closed -$108K – 596
2025
Q1 		$108K Buy
+14,255
New +$137K 0.04% 438

Other funds holding CGEM

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.23B AUM 121.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Blue Owl Capital Holdings
Blue Owl Capital Holdings New York $548M AUM 35.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM

AXQ Capital's CGEM Position: Q3 2026 in Review

AXQ Capital sold out of Cullinan Oncology (CGEM) in Q3 2026, closing a stake of 14,935 shares — an estimated $272K sold.

AXQ Capital first reported a position in CGEM in Q1 2025 and held it in 3 quarters. The position peaked at $272K in Q2 2026. 115 funds tracked by Wall St. Rank hold CGEM as of Q3 2026.

  • AXQ Capital reported no remaining Cullinan Oncology position as of Q3 2026 after selling out during the quarter.
  • AXQ Capital sold 14,935 Cullinan Oncology shares in Q3 2026, an estimated $272K.
  • AXQ Capital first reported a position in Cullinan Oncology in Q1 2025 and held it in 3 quarters.
  • AXQ Capital's Cullinan Oncology position peaked at $272K in Q2 2026.
  • 115 funds tracked by Wall St. Rank held Cullinan Oncology as of Q3 2026.

Based on AXQ Capital's 13F filing for Q3 2026, filed 12 Nov 2026.